IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q2 2016 Holdings

Filed 2016-08-15 | 34 holdings | $54.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$47.3M4,989,21887.8%
Cytomx Therapeutics Inc(CTMX)COM23284F105$6.2M606,13811.5%
Blueprint Medicines Corp(2L9)COM09627Y109$58.6K2,895,2510.1%
Chemocentryx Inc(CCXIEUR)COM16383L106$36.7K8,182,0520.1%
Exelixis IncNOTE 4.250% 8/130161QAC8$33.9K$22,822,7780.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$30.9K2,755,3180.1%
Array Biopharma Inc(ARRYEUR)COM04269X105$29.4K8,260,8970.1%
Forward Pharma A/SSPONSORED ADR34986J105$25.9K1,424,6110.0%
Ionis Pharmaceuticals Inc(IONS)COM462222100$19.8K850,0000.0%
Glycomimetics Inc(GLYCEUR)COM38000Q102$17.8K2,447,4150.0%
Cascadian Therapeutics IncCOM14740B101$17.7K18,799,3680.0%
Oncomed Pharmaceuticals IncCOM68234X102$16.5K1,339,3360.0%
Tobira Therapeutics IncCOM88883P101$15.7K1,253,4010.0%
CTI Biopharma CorpCOM12648L106$15.2K44,796,9400.0%
Arqule Inc(ARQLUSD)COM04269E107$14.2K7,450,1280.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$10.5K1,775,5720.0%
Nivalis Therapeutics IncCOM65481J109$8.9K1,926,4430.0%
Vitae Pharmaceuticals IncCOM92847N103$8.2K761,0790.0%
Paratek Pharmaceuticals IncCOM699374302$8.0K575,0000.0%
Infinity Pharmaceuticals Inc(INFIQ)COM45665G303$6.9K5,184,6000.0%
GTX Inc delCOM40052B108$6.3K11,512,0000.0%
Aduro Biotech Inc(ADROEUR)COM00739L101$5.8K513,6030.0%
Macrogenics Inc(MGNX)COM556099109$5.4K200,0000.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$4.9K499,1420.0%
Pain Therapeutics IncCOM69562K100$4.7K2,149,9130.0%
QLT IncCOM746927102$3.2K2,255,4760.0%
Sunesis Pharmaceuticals IncCOM NEW867328601$2.6K4,813,2940.0%
Orexigen Therapeutics IncCOM686164104$2.3K5,252,1000.0%
Mast Therapeutics IncCOM576314108$1.7K3,696,9610.0%
Catalyst Biosciences IncCOM14888D109$1.5K970,9480.0%
Globeimmune Inc(GBIM)COM37957B100$1.3K657,6530.0%
Calithera Biosciences Inc(CALAEUR)COM13089P101$450121,4000.0%
Pieris Pharmaceuticals IncCOM720795103$389241,3520.0%
Aviragen Therapeutics IncCOM053761102$292208,3530.0%